Skip to main content
SpringerLink
Log in
Book cover
  • Book
  • © 2006

Drugs Affecting Growth of Tumours

Birkhäuser

Editors:

  1. Herbert M. Pinedo

    1. Department of Medical Oncology, VU Medical Center, Amsterdam, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Carolien H. Smorenburg

    1. Department of Medical Oncology, VU Medical Center, Amsterdam, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Overview of relevant pharmacology and clinical data on anticancer agents
  • Written by international authorities
  • Includes supplementary material: sn.pub/extras

Part of the book series: Milestones in Drug Therapy (MDT)

Sections

Buy it now

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (9 chapters)

  1. Front Matter

    Pages I-IX
    PDF

  2. Antimetabolites

    • Kenneth W. Wyman, Igor Puzanov, Kenneth R. Hande
    Pages 1-18

  3. DNA-intercalators — the anthracyclines

    • Klaus Mross, Ulrich Massing, Felix Kratz
    Pages 19-81

  4. Topoisomerase inhibitors

    • Hans Gelderblom, Alex Sparreboom
    Pages 83-100

  5. Tubulin interacting agents

    • Manon T. Huizing
    Pages 101-131

  6. Vaccination therapies in solid tumors

    • Alfonsus J. M. van den Eertwegh
    Pages 133-151

  7. Oral anticancer agents

    • Carolien H. Smorenburg1, Alex Sparreboom
    Pages 153-166

  8. Anti-angiogenesis agents

    • Bart C. Kuenen
    Pages 167-183

  9. Signal transduction inhibitors

    • Ferry A. L. M Eskens
    Pages 185-199

  10. Endocrine therapy of breast cancer

    • Rosalba Torrisi, Alessandra Balduzzi, Aron Goldhirsch
    Pages 201-230

  11. Back Matter

    Pages 231-237
    PDF
Back to top

About this book

During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.

This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics.

Back to top

Keywords

Back to top

Editors and Affiliations

  • Department of Medical Oncology, VU Medical Center, Amsterdam, The Netherlands

    Herbert M. Pinedo, Carolien H. Smorenburg

Back to top

Bibliographic Information

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation